Aug 14, 2019 / 01:00PM GMT
Operator
Good morning and welcome to Onconova Therapeutics Corporate Update and Second Quarter 2019 Financial Results Conference Call. At this time, I would like to turn the call over to Avi Oler, Vice President of Corporate Development and General Counsel.
Abraham N. Oler - Onconova Therapeutics, Inc. - VP of Corporate Development & General Counsel
Thank you, operator. Good morning, everybody, and welcome to Onconova's Second Quarter 2019 Corporate Update and Financial Results Conference Call. Earlier this morning, we issued a press release with second quarter 2019 financial results and business updates. If you have not seen this morning's press release, it is available on the Investor Relations page of our website at www.onconova.com.
On today's call, Dr. Steven Fruchtman, President and CEO, will discuss the company's recent highlights and anticipated clinical and business progress. After Steve completed his opening remarks, Mark Guerin, our Chief Financial Officer, will review second quarter
Q2 2019 Onconova Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot